60 Gilead sales propped up by COVID-19 drug Veklury
Bio Pharma Dive
FEBRUARY 5, 2021
Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere
Sales Related Topics 
Pfizer forecasts $15B sales boost from coronavirus vaccine orders
Bio Pharma Dive
FEBRUARY 2, 2021
The estimate for 2021 sales, which Pfizer splits with partner BioNTech, would make the vaccine one of the highest-selling medicines in the industry
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Vaccine sales driven down by pandemic's effects on doctor visits
Bio Pharma Dive
JULY 31, 2020
Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations
Novartis expects sales lift from expanded heart drug approval
Bio Pharma Dive
FEBRUARY 17, 2021
The Swiss drugmaker's pill Entresto is now cleared in the U.S. for use in patients with stronger hearts, expanding the eligible population by two-thirds
LARVOL Appoints New Vice President, Global Sales
BioTech 365
FEBRUARY 23, 2021
LARVOL Appoints New Vice President, Global Sales LARVOL Appoints New Vice President, Global Sales SAN FRANCISCO–(BUSINESS WIRE)–LARVOL, leading provider of intelligence and data solutions to pharma and life science teams, today welcomes Mark Lagunowich as Vice President, Global Sales. “We
New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe
Pharma Mirror
FEBRUARY 25, 2021
Borja Guerra has been appointed new Sales & Service Director of Romaco Kilian in Cologne. The Romaco facilities in Bologna and Karlsruhe likewise have new Sales Directors: Massimiliano Cesarini and Ralph Augenstein.
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
BioTech 365
FEBRUARY 8, 2021
Eton Pharmaceuticals Announces Sale of Neurology Portfolio Eton Pharmaceuticals Announces Sale of Neurology Portfolio Eton to receive up to $45 million plus royalties on product sales DEER PARK, Ill., 08, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. Nasdaq: ETON), … Continue reading → GlobeNewswire
Gilead lifted by fast sales of COVID-19 drug Veklury. Will they last?
Bio Pharma Dive
OCTOBER 29, 2020
sales seem likely to slow in the months ahead Veklury, which was fully approved by the FDA last week, earned Gilead nearly $900 million in the third quarter, although U.S.
HealthEquity Announces Closing of Sale of Additional Shares
BioTech 365
MARCH 2, 2021
HealthEquity Announces Closing of Sale of Additional Shares HealthEquity Announces Closing of Sale of Additional Shares DRAPER, Utah, March 02, 2021 (GLOBE NEWSWIRE) — HealthEquity, Inc. NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering … Continue reading → GlobeNewswire
Sales targets and bonuses drove Celgene, Teva drug price hikes, lawmakers charge
Bio Pharma Dive
OCTOBER 1, 2020
An 18-month investigation by the House Oversight Committee targeted the pricing practices behind the top-selling drugs Revlimid and Copaxone
Douglas generates record e-commerce sales in the Christmas quarter
BioTech 365
FEBRUARY 26, 2021
E-commerce sales rise by more than 74 percent to 433 million euros in Q1 2020/21 Q1 (Oct-Dec) Group sales of 1.2 billion euros despite hard lockdown in the core markets of Germany and France during Christmas business Q1 e-commerce share in … Continue reading → EQS Newsfeed
Amgen’s Sales Team Faces Layoffs, Hundreds of Jobs Cut at Headquarters
BioSpace
FEBRUARY 3, 2021
jobs, the majority of which are centered on the company’s sales team, according to a recent sales call Amgen is in the process of eliminating hundreds of U.S.
Pure Extracts Submits Application to Health Canada for Sales License
BioTech 365
FEBRUARY 22, 2021
Pure Extracts Submits Application to Health Canada for Sales License Pure Extracts Submits Application to Health Canada for Sales License VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure … Continue reading → GlobeNewswire
HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales
BioTech 365
FEBRUARY 22, 2021
HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales On Track to Complete Business Combination with Vesper Healthcare in the First Half of 2021 MIAMI BEACH, Fla. &
Medicenna Establishes At-the-Market Sales Facility
BioTech 365
DECEMBER 30, 2020
Medicenna Establishes At-the-Market Sales Facility Medicenna Establishes At-the-Market Sales Facility TORONTO and HOUSTON, Dec. 30, 2020 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical stage immuno-oncology company, announced today that it has entered … Continue reading → GlobeNewswire
Takeda agrees $2.3bn sale of Japanese consumer health unit
Pharma Phorum
AUGUST 24, 2020
Takeda Consumer Healthcare sells OTC medicines and other health products with sales of 60 billion yen ($567 million) in fiscal 2019. It also comes after chief executive Christophe Weber said the sale of the consumer health unit was “unlikely” last year.
P360 Adds Advanced Artificial Intelligence Capabilities to its Sales Enablement Platform BirdzAI
Pharma Phorum
SEPTEMBER 22, 2020
Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI . P360 , a leading developer of technology for life sciences companies, today announced major updates to its sales enablement platform BirdzAI.
Takeda Completes Sale of TachoSil® to Corza Health
BioTech 365
JANUARY 31, 2021
Takeda Completes Sale of TachoSil® to Corza Health Takeda Completes Sale of TachoSil® to Corza Health OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch (“TachoSil®”) … Continue reading → Business Wire
SHINE Announces First Sales of Its Non-carrier-added Lutetium-177
BioTech 365
NOVEMBER 4, 2020
SHINE Announces First Sales of Its Non-carrier-added Lutetium-177 SHINE Announces First Sales of Its Non-carrier-added Lutetium-177 JANESVILLE, Wis.–(BUSINESS
GSK sees dip in second-quarter sales
Pharma Times
JULY 30, 2020
Sales decline in the second quarter reflects expected disruption from COVID-19
Biotech In-Demand Job: Regional Sales Manager
BioSpace
FEBRUARY 3, 2021
Not every biotech job is heavily rooted in science. Some rely on additional skills, like those of communication, organization and more in order to play a crucial role in the industry
Purdue, reaching $8B settlement with US, pleads guilty to charges over opioid sales
Bio Pharma Dive
OCTOBER 21, 2020
Under a deal reached with the Department of Justice, Purdue faces fines and a forfeiture worth more than $5 billion — the largest penalties ever for a drug company
Takeda Completes Sale of Select Non-Core Assets to Cheplapharm
BioTech 365
JANUARY 4, 2021
Takeda Completes Sale of Select Non-Core Assets to Cheplapharm Takeda Completes Sale of Select Non-Core Assets to Cheplapharm OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select prescription … Continue reading → Business Wire
PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares
BioTech 365
FEBRUARY 9, 2021
Gilead Q3 revenue rise bolstered by $873m Veklury sales
Pharma Phorum
OCTOBER 29, 2020
billion at a time when most other pharma companies have seen sales growth pegged back by restricted access to healthcare during pandemic lockdowns. The bulk of the Veklury sales ($785 million) were in the US, with Europe accounting for a sizeable chunk of the remainder. The post Gilead Q3 revenue rise bolstered by $873m Veklury sales appeared first on. News Sales and Marketing coronavirus COVID-19 Financial Gilead Sciences remdesivir Veklury
Edgemont Partners Advises Bridges Inc. on Sale to Proud Moments ABA
BioTech 365
FEBRUARY 8, 2021
on Sale to Proud Moments ABA Edgemont Partners Advises Bridges Inc. Edgemont Partners Advises Bridges Inc.
Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales
XTalks
MARCH 1, 2021
Anti-inflammatory drugs like Restasis and Xiidra are popular treatment options for the condition, but will the emergence of mask-associated dry eye bolster their sales? The post Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales appeared first on Xtalks.
Lundbeck tops Q3 expectations following strong sales of mental health drugs
Pharma Phorum
NOVEMBER 3, 2020
Lundbeck posted quarterly sales of 4.46 The performance was thanks to increased sales of its mental health drug Abilify Maintena, which increased 19% in the first nine months of the year compared with the same period last year to 1.729 billion Danish kroner ($270 million).
United States HIV Infection Drug Market, Dosage, Price, Sales Insight Report 2021-2026 – ResearchAndMarkets.com
BioTech 365
FEBRUARY 22, 2021
United States HIV Infection Drug Market, Dosage, Price, Sales Insight Report 2021-2026 – ResearchAndMarkets.com United States HIV Infection Drug Market, Dosage, Price, Sales Insight Report 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 … Continue reading → Business Wire
2020 Financial Year: Solid Performance Despite Decline in Sales
BioTech 365
MARCH 4, 2021
COLTENE Holding AG / Key word(s): Annual Results 05-March-2021 / 06:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Due to global COVID-19 pandemic, net … Continue reading → EQS Newsfeed
COVID-19 ventilator demand fuels Philips Q3 sales
Pharma Phorum
OCTOBER 20, 2020
Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Dutch health technology group reported sales of €4.98bn, a 10% year-over-year growth. Sales were down 3%, to €1.97bn compared to a 9% dip in Q2.
Soliton Appoints Sean J. Shapiro as Vice President of Sales
The Pharma Data
DECEMBER 29, 2020
Shapiro as Vice President of Sales, effective January 1, 2021. a Women’s Health Company which manufactures patented CMRF Technology, where he recruited a sales team which generated approximately $11 million in revenue in the year of launch. .
HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel
BioTech 365
JANUARY 21, 2021
HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel DENVER–(BUSINESS WIRE)–$CBD.U #CBD–HempFusion
EDAP Announces End of the Year Focal One® Sales
BioTech 365
DECEMBER 30, 2020
EDAP Announces End of the Year Focal One® Sales EDAP Announces End of the Year Focal One® Sales Among December deals closed, two major US institutions have purchased Focal One University of California, San Francisco Medical Center and Cleveland Clinic … Continue reading → GlobeNewswire
Y-mAbs Announces Sale of Priority Review Voucher
BioTech 365
DECEMBER 28, 2020
Y-mAbs Announces Sale of Priority Review Voucher Y-mAbs Announces Sale of Priority Review Voucher NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and … Continue reading → GlobeNewswire
LUM001 Insight and Market Sales Forecast Report 2020-2030 – ResearchAndMarkets.com
BioTech 365
DECEMBER 18, 2020
LUM001 Insight and Market Sales Forecast Report 2020-2030 – ResearchAndMarkets.com LUM001 Insight and Market Sales Forecast Report 2020-2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “LUM001 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
Novartis CEO thinks 2nd health lockdown unlikely, as Q3 sales stabilise
Pharma Phorum
OCTOBER 27, 2020
Novartis’ pharmaceutical sales recovered in the third quarter of this year after an earlier COVID-19 decline, as new drugs like gene therapy Zolgensma gathered pace. . Correcting for currency fluctuations, net sales were flat at $12.3
Medios AG achieves 2020 annual targets – sales expected to almost double in 2021
BioTech 365
MARCH 1, 2021
Press Release Medios AG achieves 2020 annual targets – sales expected to almost double in 2021 … Continue reading → EQS NewsfeedDGAP-News: Medios AG / Key word(s): Preliminary Results/Change in Forecast 01.03.2021 / 11:30 The issuer is solely responsible for the content of this announcement.
R-Zero Poised to be a Breakthrough Leader in Enterprise Biosafety with Record Sales in First Year
BioTech 365
JANUARY 14, 2021
R-Zero Poised to be a Breakthrough Leader in Enterprise Biosafety with Record Sales in First Year R-Zero Poised to be a Breakthrough Leader in Enterprise Biosafety with Record Sales in First Year Millions in Sales Booked Within Just Three Months … Continue reading → Business Wire
A Successful Rights Issue with Focus on Sales!
BioTech 365
NOVEMBER 12, 2020
A Successful Rights Issue with Focus on Sales! A Successful Rights Issue with Focus on Sales! Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Successful Rights Issue with Focus on … Continue reading → GlobeNewswire
Coaching sales agents? Use AI and human coaches
Scienmag
NOVEMBER 19, 2020
News from the Journal of Marketing Researchers from Temple University, Sichuan University, and Fudan University published a new paper in the Journal of Marketing that explores the growing use of AI to coach sales agents to determine if there are any caveats that inhibit the effective use of this technology.
Pure Extracts Announces Its First Commercial Sale of CBD Oil on the Wholesale Market
BioTech 365
FEBRUARY 9, 2021
Pure Extracts Announces Its First Commercial Sale of CBD Oil on the Wholesale Market Pure Extracts Announces Its First Commercial Sale of CBD Oil on the Wholesale Market VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies … Continue reading → GlobeNewswire
Let's personalize your content